Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer.
Stein L, Murugesan K, Reeser JW, Risch Z, Wing MR, Paruchuri A, Samorodnitsky E, Hoskins EL, Dao T, Smith A, Le D, Babcook MA, Chang YS, Avenarius MR, Imam M, Freud AG, Roychowdhury S. Stein L, et al. Among authors: samorodnitsky e. NPJ Precis Oncol. 2024 Sep 17;8(1):207. doi: 10.1038/s41698-024-00683-x. NPJ Precis Oncol. 2024. PMID: 39289482 Free PMC article.
Analytic validation of an FGFR -focused cell-free DNA liquid biopsy assay (FGFR-Dx).
Reeser JW, Wing MR, Samorodnitsky E, Dao T, Smith A, Stein L, Paruchuri A, Miya J, Bonneville R, Chang YS, Avenarius M, Freud AG, Yu L, Roychowdhury S. Reeser JW, et al. Among authors: samorodnitsky e. medRxiv [Preprint]. 2024 Sep 1:2024.09.01.24312783. doi: 10.1101/2024.09.01.24312783. medRxiv. 2024. PMID: 39252898 Free PMC article. Preprint.
Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib.
Risch Z, Kaffenberger BH, Chung CG, Samorodnitsky E, Hoskins EL, Dao T, Smith A, Wall SA, Brammer J, Reeser JW, Wing MR, Hopkins JF, Albacker LA, Abruzzo LV, Eisele CD, Freud AG, Roychowdhury S, Walsh KE. Risch Z, et al. Among authors: samorodnitsky e. Haematologica. 2024 Nov 1;109(11):3816-3820. doi: 10.3324/haematol.2024.285146. Haematologica. 2024. PMID: 38813710 Free PMC article. No abstract available.
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations.
Hoskins EL, Samorodnitsky E, Wing MR, Reeser JW, Hopkins JF, Murugesan K, Kuang Z, Vella R, Stein L, Risch Z, Yu L, Adebola S, Paruchuri A, Carpten J, Chahoud J, Edge S, Kolesar J, McCarter M, Nepple KG, Reilley M, Scaife C, Tripathi A, Single N, Huang RSP, Albacker LA, Roychowdhury S. Hoskins EL, et al. Among authors: samorodnitsky e. JCO Precis Oncol. 2023 Jan;7:e2200300. doi: 10.1200/PO.22.00300. JCO Precis Oncol. 2023. PMID: 36623238 Free PMC article.
Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy.
Chen HZ, Bonneville R, Paruchuri A, Reeser JW, Wing MR, Samorodnitsky E, Krook MA, Smith AM, Dao T, Miya J, Wang W, Yu L, Freud AG, Allenby P, Cole S, Otterson G, Shields P, Carbone DP, Roychowdhury S. Chen HZ, et al. Among authors: samorodnitsky e. JTO Clin Res Rep. 2021 Mar 11;2(4):100164. doi: 10.1016/j.jtocrr.2021.100164. eCollection 2021 Apr. JTO Clin Res Rep. 2021. PMID: 34590014 Free PMC article.
Characterization of Clonal Evolution in Microsatellite Unstable Metastatic Cancers through Multiregional Tumor Sequencing.
Bonneville R, Paruchuri A, Wing MR, Krook MA, Reeser JW, Chen HZ, Dao T, Samorodnitsky E, Smith AM, Yu L, Nowacki N, Chen W, Roychowdhury S. Bonneville R, et al. Among authors: samorodnitsky e. Mol Cancer Res. 2021 Mar;19(3):465-474. doi: 10.1158/1541-7786.MCR-19-0955. Epub 2020 Nov 23. Mol Cancer Res. 2021. PMID: 33229401 Free PMC article.
Research Autopsy Demonstrates Polyclonal Acquired Resistance in a Patient With Metastatic GI Stromal Tumor.
Paruchuri A, Chen HZ, Bonneville R, Reeser JW, Wing MR, Krook MA, Samorodnitsky E, Miya J, Dao T, Smith A, Freud AG, Allenby P, Roychowdhury S. Paruchuri A, et al. Among authors: samorodnitsky e. JCO Precis Oncol. 2020 Mar 3;4:PO.19.00328. doi: 10.1200/PO.19.00328. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32923900 Free PMC article. No abstract available.
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma.
Krook MA, Lenyo A, Wilberding M, Barker H, Dantuono M, Bailey KM, Chen HZ, Reeser JW, Wing MR, Miya J, Samorodnitsky E, Smith AM, Dao T, Martin DM, Ciombor KK, Hays J, Freud AG, Roychowdhury S. Krook MA, et al. Among authors: samorodnitsky e. Mol Cancer Ther. 2020 Mar;19(3):847-857. doi: 10.1158/1535-7163.MCT-19-0631. Epub 2020 Jan 7. Mol Cancer Ther. 2020. PMID: 31911531 Free PMC article.
Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy.
Krook MA, Bonneville R, Chen HZ, Reeser JW, Wing MR, Martin DM, Smith AM, Dao T, Samorodnitsky E, Paruchuri A, Miya J, Baker KR, Yu L, Timmers C, Dittmar K, Freud AG, Allenby P, Roychowdhury S. Krook MA, et al. Among authors: samorodnitsky e. Cold Spring Harb Mol Case Stud. 2019 Aug 1;5(4):a004002. doi: 10.1101/mcs.a004002. Print 2019 Aug. Cold Spring Harb Mol Case Stud. 2019. PMID: 31371345 Free PMC article.
21 results